| Recruitment status | Open public recruiting |
| Unique ID issued by UMIN | UMIN000022922 |
| Receipt No. | R000026415 |
| Official scientific title of the study | Comparison of vonoprazan-based dual therapy with amoxicillin and the triple therapy with amoxicillin and clarithromycin for H. Pylori Eradication |
| Date of disclosure of the study information | 2016/07/01 |
| Last modified on | 2017/12/29 (Ver. 4) |
| Basic information | ||
| Official scientific title of the study | Comparison of vonoprazan-based dual therapy with amoxicillin and the triple therapy with amoxicillin and clarithromycin for H. Pylori Eradication
|
|
| Title of the study (Brief title) | Comparison of Vonoprazan-based Dual and Triple Therapies for H. Pylori Eradication
|
|
| Region |
|
|
| Condition | ||
| Condition | H. pylori infection | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To compare the eradication rate with the dual therapy with vonoprazan 20 mg bid and amoxicillin 500 mg tid with those with the triple therapy with vonoprazan 20 mg bid, amoxicillin 750 mg bid and metronidazole 250 mg bid for 1 week. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | eradication rates of H. pylori |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | Active |
| Stratification | YES |
| Dynamic allocation | NO |
| Institution consideration | Institution is not considered as adjustment factor. |
| Blocking | YES |
| Concealment | Pseudo-randomization |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Triple therapy with vonoprazan 20 mg bid, amoxicillin 750 mg bid and clarithromycin 200 mg or metronidazole 250 mg bid for 1 week.
|
|
| Interventions/Control_2 | The dual therapy with vonoprazan 20 mg bid and amoxicillin 500 mg tid for 1 week | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients infected with H. pylori
Patients who agree to participate to the study |
|||
| Key exclusion criteria | Patients who do not agree to participate to the study
Patients who had ever failed in eradication of H. pylori no less than 2 times. Patients who are allergic to any of drugs used in this study Patients who are considered inappropriate to participate to the study by the doctor |
|||
| Target sample size | 100 | |||
| Research contact person | |
| Name of lead principal investigator | Takahisa Furuta |
| Organization | Hamamatsu University School of Medicine |
| Division name | Center for Clinical Research |
| Address | 1-20-1, Handayama, HigashiKu, Hamamatsu, 431-3192, Japan |
| TEL | 053-435-2850 |
| furuta@hama-med.ac.jp | |
| Public contact | |
| Name of contact person | Takahisa Furuta |
| Organization | Hamamatsu University School of Medicine |
| Division name | Center for Clinical Research |
| Address | 1-20-1, Handayama, HigashiKu, Hamamatsu, 431-3192, Japan |
| TEL | 053-435-2850 |
| Homepage URL | |
| furuta@hama-med.ac.jp | |
| Sponsor | |
| Institute | Ministry of health, labor and welfare |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Self funding |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | R15-006 |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 浜松医科大学付属病院 |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Open public recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000026415 |